Executive Moves | Healthcare | BioTuesdays by Kilmer Lucas IR

Executive Moves

PharmaJet appoints Melissa Malhame as VP business development

Closely-held PharmaJet appointed Melissa Malhame as its VP of business development, where she will lead the company’s business development, sales, and marketing operations. “[Ms. Malhame’s] strategic business...

September 29, 2020

Executive Moves

Eric Cheng joins Altium Capital as a managing director

After 23 years in investment banking, Eric Cheng has joined Altium Capital Management, an investment firm based in New York focused on the healthcare industry. Mr. Cheng most recently was managing director and head of...

September 1, 2020

Executive Moves

Perimeter Medical Imaging names Aaron Davidson to its board

Perimeter Medical Imaging (TSXV:PINK) appointed Aaron Davidson, currently CFO and SVP of corporate development at Profound Medical (TSX-V:PRN; OTCQX:PRFMF), to its board of directors. “[Mr. Davidson’s] experience at...

August 26, 2020

Executive Moves

Kane Biotech appoints renowned wound care and biofilms expert, Dr. Gregory Schultz, as scientific advisor

Kane Biotech (TSX-V:KNE) appointed wound care and biofilms expert, Dr. Gregory Schultz, as a scientific advisor. Dr. Schultz is the director of the Institute for Wound Research and professor of obstetrics and gynecology...

August 12, 2020

Executive Moves

Pacific Biosciences names Christian Henry as president and CEO

Pacific Biosciences (NASDAQ:PACB) appointed Christian Henry as president and CEO, effective Sept. 14. Mr. Henry will replace Michael Hunkapiller, who will retire at the end of 2020. Current Pacific Biosciences board...

August 7, 2020

Executive Moves

Zenabis names Shai Altman as president and CEO

Zenabis Global (TSX:ZENA) appointed Shai Altman as president and CEO, effective September 1. Mr. Altman will replace interim CEO, Kevin Coft, who will return to his role as Zenabis’ chief facilities officer. Mr. Altman...

July 31, 2020

Executive Moves

Canaccord boosts healthcare investment banking team

Canaccord Genuity named Thomas O’Connor as managing director, co-head of U.S. healthcare investment banking, with long-time partners, Matt Steere and Eugene Rozelman, joining Mr. O’Connor as fellow co-heads of the U.S...

July 23, 2020

Executive Moves

Rhythm Pharma appoints Dr. David Meeker as CEO

Rhythm Pharmaceuticals (NASDAQ:RYTM) appointed its chairman, Dr. David Meeker as CEO, effective immediately. Dr. Meeker replaces interim president and CEO, Hunter Smith, who will continue in his role as CFO. Dr. Meeker...

July 20, 2020

Executive Moves

Sun BioPharma names Jennifer Simpson as president and CEO

Sun BioPharma (OTCQB:SNBP) appointed Jennifer Simpson as president and CEO, replacing co-founder Michael Cullen, who will continue to serve as the company’s executive chairman. Dr. Simpson has more than 25 years of...

July 17, 2020

Executive Moves

Neuronetics names Keith Sullivan as president and CEO

Neuronetics (NASDQ:STIM) appointed Keith Sullivan as president and CEO, effective immediately. Christopher Thatcher, the company’s previous president and CEO, resigned in March 2020. Mr. Sullivan has more than three...

July 14, 2020

Executive Moves

Elemer Piros rejoins Roth healthcare research team

Elemer Piros has rejoined the healthcare research team at Roth Capital Partners as managing director, senior research analyst covering biotechnology. His research coverage is expected to include small- and mid-cap...

July 9, 2020

Executive Moves

Strongbridge Biopharma names John Johnson as CEO

Strongbridge Biopharma (NASDAQ:SBBP) appointed its executive chairman, John Johnson, as the company’s CEO, effective immediately. Mr. Johnson served as Strongbridge’s chairman since March 2015. In November 2019, he took...

July 7, 2020

Executive Moves

Chimerix appoints Allen Melemed as CMO

Chimerix (NASDAQ:CMRX) appointed Dr. Allen Melemed as its CMO. Dr. Melemed was most recently a distinguished medical fellow and senior director of North American regulatory affairs oncology at Eli Lilly (NYSE:LLY). He...

June 22, 2020

Executive Moves

NeuroOne appoints neural engineering expert, Camilo Andres Diaz-Botia, as director of electrode development

NeuroOne Medical Technologies (OTCQB:NMTC) appointed neural engineer, Camilo Andres Diaz-Botia, as director of electrode development. Dr. Diaz-Botia previously led the microfabrication process engineering team at...

June 17, 2020

Executive Moves

Hepion names drug development expert, Dr. Peter Wijngaard, to its board

Hepion Pharmaceuticals (NASDAQ:HEPA) appointed industry veteran, Dr. Peter Wijngaard, to its board of directors. “Dr. Wijngaard provided invaluable guidance to Hepion’s management team during our earlier work on...

June 10, 2020

Executive Moves

AMAG Pharma appoints Scott Myers as president and CEO

AMAG Pharmaceuticals (NASDAQ:AMAG) appointed Scott Myers as its president and CEO, and a member of the board, effective immediately. Mr. Myers was most recently chairman and CEO of Rainier Therapeutics. He replaces...

April 28, 2020

Executive Moves

PharmaJet appoints Chris Cappello as president and CEO

Closely-held PharmaJet appointed Chris Cappello as its president and CEO, replacing Ron Lowy, who was appointed as executive chairman. “In the 10 years that [Mr.Cappello] has worked for PharmaJet, he has shown the...

April 28, 2020

Executive Moves

TerrAscend appoints Jason Ackerman as permanent CEO; CFO to step down

TerrAscend (OTCQX:TRSSF) appointed Jason Ackerman as CEO and reported that its CFO, Adam Kozak, will step down as the company relocates its financial operations from Toronto to New York City. Mr. Ackerman joined...

April 14, 2020

Executive Moves

Five Prime Therapeutics appoints industry leader, Tom Civik, as CEO

Five Prime Therapeutics (NASDAQ:FPRX) appointed Tom Civik as president, CEO and a director. William Ringo, who served as Five Prime’s chairman and interim CEO since September 2019, will step down as CEO and continue as...

April 14, 2020

Executive Moves

Dr. Anjay Rastogi joins XORTX Therapeutics CAB

Dr. Anjay Rastogi has joined the clinical advisory board of XORTX Therapeutics (CSE:XRX; OTCQB:XRTXF), bringing professional experience as a thought leader, combined with clinical experience treating patients with...

March 26, 2020

Executive Moves

Akcea names Damien Devitt as CEO

Damien Devitt, who has been interim CEO of Akcea Therapeutics (NASDAQ:AKCA) since September 2019, has been promoted to CEO, effective immediately, and will continue to serve as a member of Akcea’s board. “With his...

March 24, 2020

Executive Moves

iBio appoints accomplished life sciences executive, Thomas Isett, as co-chairman and CEO

iBio (NYSE AMERICAN:IBIO) appointed Thomas Isett, a current iBio board member, as its co-chairman and CEO. Mr. Isett succeeds Robert Kay, who has retired from the role of CEO, but will remain as co-chairman and a member...

March 12, 2020

PharmaJet appoints Melissa Malhame as VP business development

Eric Cheng joins Altium Capital as a managing director

Perimeter Medical Imaging names Aaron Davidson to its board

Kane Biotech appoints renowned wound care and biofilms expert, Dr. Gregory Schultz, as scientific advisor

Pacific Biosciences names Christian Henry as president and CEO

Zenabis names Shai Altman as president and CEO

Canaccord boosts healthcare investment banking team

Rhythm Pharma appoints Dr. David Meeker as CEO

Sun BioPharma names Jennifer Simpson as president and CEO

Neuronetics names Keith Sullivan as president and CEO

Elemer Piros rejoins Roth healthcare research team

Strongbridge Biopharma names John Johnson as CEO

Chimerix appoints Allen Melemed as CMO

NeuroOne appoints neural engineering expert, Camilo Andres Diaz-Botia, as director of electrode development

Hepion names drug development expert, Dr. Peter Wijngaard, to its board

AMAG Pharma appoints Scott Myers as president and CEO

PharmaJet appoints Chris Cappello as president and CEO

TerrAscend appoints Jason Ackerman as permanent CEO; CFO to step down

Five Prime Therapeutics appoints industry leader, Tom Civik, as CEO

Dr. Anjay Rastogi joins XORTX Therapeutics CAB

Akcea names Damien Devitt as CEO

iBio appoints accomplished life sciences executive, Thomas Isett, as co-chairman and CEO

Follow Us

General

More

Sign up for the BioTuesdays weekly newsletter